IL158985A0 - Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents - Google Patents

Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents

Info

Publication number: IL158985A0
Authority: IL; Israel
Prior art keywords: sulfonylbenzamidines; benzoylsulfonamides; antitumour agents; antitumour; agents
Prior art date: 2001-06-06

Application number

IL15898502A

Other languages

English (en)

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-06-06

Filing date

2002-05-24

Publication date

2004-05-12

2002-05-24 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

2004-05-12 Publication of IL158985A0 publication Critical patent/IL158985A0/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
- C07C311/51—Y being a hydrogen or a carbon atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/64—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton
- C07C323/67—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton containing sulfur atoms of sulfonamide groups, bound to the carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/32—Sulfur atoms
- C07D213/34—Sulfur atoms to which a second hetero atom is attached
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/18—Radicals substituted by singly bound hetero atoms other than halogen by sulfur atoms

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pyridine Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Quinoline Compounds (AREA)
Furan Compounds (AREA)

IL15898502A 2001-06-06 2002-05-24 Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents IL158985A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US29635001P	2001-06-06	2001-06-06
PCT/US2002/015142 WO2002098848A1 (en)	2001-06-06	2002-05-24	Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents

Publications (1)

Publication Number	Publication Date
IL158985A0 true IL158985A0 (en)	2004-05-12

Family

ID=23141662

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL15898502A IL158985A0 (en)	2001-06-06	2002-05-24	Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents

Country Status (36)

Country	Link
US (1)	US7183320B2 (ja)
EP (1)	EP1401806B1 (ja)
JP (1)	JP4167173B2 (ja)
KR (1)	KR100880760B1 (ja)
CN (1)	CN100475787C (ja)
AR (1)	AR036079A1 (ja)
AT (1)	ATE335722T1 (ja)
AU (1)	AU2002259204B2 (ja)
BR (1)	BR0210078A (ja)
CA (1)	CA2446719A1 (ja)
CR (1)	CR7182A (ja)
CY (1)	CY1105386T1 (ja)
CZ (1)	CZ20033296A3 (ja)
DE (1)	DE60213810T2 (ja)
DK (1)	DK1401806T3 (ja)
EA (1)	EA005810B1 (ja)
EC (1)	ECSP034874A (ja)
EG (1)	EG24356A (ja)
ES (1)	ES2269688T3 (ja)
HK (1)	HK1064360A1 (ja)
HR (1)	HRP20031000A2 (ja)
HU (1)	HUP0400114A3 (ja)
IL (1)	IL158985A0 (ja)
MX (1)	MXPA03011197A (ja)
MY (1)	MY136855A (ja)
NO (1)	NO20035366L (ja)
NZ (1)	NZ529098A (ja)
PE (1)	PE20030199A1 (ja)
PL (1)	PL367188A1 (ja)
PT (1)	PT1401806E (ja)
SK (1)	SK14642003A3 (ja)
SV (1)	SV2003001076A (ja)
TW (1)	TWI266761B (ja)
UA (1)	UA74889C2 (ja)
WO (1)	WO2002098848A1 (ja)
ZA (1)	ZA200308644B (ja)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1565438B1 (en) *	2002-11-22	2007-10-17	Eli Lilly And Company	Antitumor benzoylsulfonamides
US7767684B2 (en) *	2003-11-13	2010-08-03	Abbott Laboratories	Apoptosis promoters
WO2005049593A2 (en)	2003-11-13	2005-06-02	Abbott Laboratories	N-acylsulfonamide apoptosis promoters
US8614318B2 (en)	2003-11-13	2013-12-24	Abbvie Inc.	Apoptosis promoters
US7973161B2 (en)	2003-11-13	2011-07-05	Abbott Laboratories	Apoptosis promoters
EP1765778B1 (en) *	2004-05-26	2012-01-25	Abbott Laboratories	N-sulfonylcarboximidamide apoptosis promoters
US8772269B2 (en)	2004-09-13	2014-07-08	Eisai R&D Management Co., Ltd.	Use of sulfonamide-including compounds in combination with angiogenesis inhibitors
JP5134247B2 (ja) *	2004-09-13	2013-01-30	エーザイ・アール・アンド・ディー・マネジメント株式会社	スルホンアミド含有化合物の血管新生阻害物質との併用
EP2364699A1 (en)	2004-09-13	2011-09-14	Eisai R&D Management Co., Ltd.	Joint use of sulfonamide based compound with angiogenesis inhibitor
WO2006090921A1 (ja) *	2005-02-28	2006-08-31	Eisai R & D Management Co., Ltd.	スルホンアミド化合物のリンパ球活性化抑制作用
CA2599301A1 (en) *	2005-02-28	2006-08-31	Eisai R & D Management Co., Ltd.	Novel use of sulfonamide compound in combination with angiogenesis inhibitor
AU2006217692A1 (en)	2005-02-28	2006-08-31	Eisai R & D Management Co., Ltd.	Novel combinational use of sulfonamide compound
US8624027B2 (en)	2005-05-12	2014-01-07	Abbvie Inc.	Combination therapy for treating cancer and diagnostic assays for use therein
ES2493466T3 (es)	2005-05-12	2014-09-11	Abbvie Bahamas Ltd.	Promotores de la apoptosis
US7208526B2 (en)	2005-05-20	2007-04-24	Hoffmann-La Roche Inc.	Styrylsulfonamides
US7208506B2 (en) *	2005-07-07	2007-04-24	Hoffmann-La Roche Inc.	Heteroarylethenyl derivatives, their manufacture and use as pharmaceutical agents
US7625896B2 (en) *	2005-11-25	2009-12-01	Hoffman-La Roche Inc.	Pyridylsulfonamide derivatives
WO2007123274A1 (ja)	2006-04-20	2007-11-01	Eisai R & D Management Co., Ltd.	スルホンアミド化合物の新規感受性マーカー
CN101534904B (zh)	2006-09-05	2013-11-06	Abbvie公司	治疗血小板过量的bcl抑制剂
US7939532B2 (en) *	2006-10-26	2011-05-10	Hoffmann-La Roche Inc.	Heterocyclyl pyridyl sulfonamide derivatives, their manufacture and use as pharmaceutical agents
JP2010526844A (ja) *	2007-05-16	2010-08-05	エフ．ホフマン−ラロシュアーゲー	アリールピリジルスルホンアミド誘導体、それらの製造法及び医薬剤としての使用
US20100160322A1 (en)	2008-12-04	2010-06-24	Abbott Laboratories	Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
US8557983B2 (en)	2008-12-04	2013-10-15	Abbvie Inc.	Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
US8586754B2 (en)	2008-12-05	2013-11-19	Abbvie Inc.	BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
US8563735B2 (en)	2008-12-05	2013-10-22	Abbvie Inc.	Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
CA2747835A1 (en) *	2009-01-19	2010-07-22	Abbott Laboratories	Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
JP2012136435A (ja) *	2009-03-30	2012-07-19	Eisai R & D Management Co Ltd	腫瘍組織の感受性を検査する方法
KR200457823Y1 (ko) *	2009-05-08	2012-01-05	황정용	쭈꾸미 포획용 어구
KR20190130676A (ko)	2009-05-26	2019-11-22	애브비 아일랜드 언리미티드 컴퍼니	암，면역 질환 및 자가면역 질환의 치료를 위한 아폽토시스-유도제
US8546399B2 (en)	2009-05-26	2013-10-01	Abbvie Inc.	Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
US9034875B2 (en)	2009-05-26	2015-05-19	Abbvie Inc.	Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
US20220315555A1 (en)	2009-05-26	2022-10-06	Abbvie Inc.	Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
AU2011229862B2 (en) *	2010-03-25	2014-07-24	Abbvie Inc.	Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
UA113500C2 (xx)	2010-10-29	2017-02-10		Одержані екструзією розплаву тверді дисперсії, що містять індукуючий апоптоз засіб
NZ608274A (en)	2010-10-29	2015-05-29	Abbvie Inc	Solid dispersions containing an apoptosis-inducing agent
PL2643322T3 (pl)	2010-11-23	2018-02-28	Abbvie Inc.	Sole i postaci krystaliczne środka indukującego apoptozę
SG190399A1 (en)	2010-11-23	2013-06-28	Abbvie Inc	Methods of treatment using selective bcl-2 inhibitors
CN103159650B (zh) *	2011-12-19	2016-04-20	天津市国际生物医药联合研究院	芳香杂环磺酰胺类化合物的制备及其应用
CN103159649B (zh) *	2011-12-19	2016-03-09	天津市国际生物医药联合研究院	磺酰胺类化合物的制备及其应用
US20140275082A1 (en)	2013-03-14	2014-09-18	Abbvie Inc.	Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
CN105712925B (zh) *	2014-12-05	2019-01-04	沈阳中化农药化工研发有限公司	一种取代的磺酰胺基(硫代)羰基化合物及其用途
JP6740256B2 (ja)	2015-02-13	2020-08-12	オックスフォードドラッグデザインリミテッド	アミノアシルｔＲＮＡシンテターゼ阻害薬としての新規なＮ−アシル−アリールスルホンアミド誘導体
CN105753748B (zh) *	2016-02-15	2018-05-29	南京励合化学新材料有限公司	一种医药中间体磺酰类化合物的合成方法
GB201617064D0 (en)	2016-10-07	2016-11-23	Inhibox Limited And Latvian Institute Of Organic Synthesis The	Compounds and their therapeutic use
US11479532B2 (en) *	2017-06-23	2022-10-25	University Of South Florida	5-aminolevulinate synthase inhibitors and methods of use thereof
EP3731839A4 (en) *	2017-12-29	2021-11-10	Gongwin Biopharm Co., Ltd. (Taiwan)	BENZENE SULFONAMIDE DERIVATIVES AND METHODS FOR MODULATING LIPID RAFTS
CN114790149B (zh) *	2021-01-26	2024-11-19	江苏中旗科技股份有限公司	一种以2-氯-4-氟苯胺为原料合成2-氯-4-氟苯甲酸的方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4157257A (en)	1976-10-01	1979-06-05	Utsunomiya University	Benzenesulfonamide derivatives
US4347380A (en) *	1979-04-20	1982-08-31	Stauffer Chemical Company	N-Acylsulfonamide herbicidal antidotes
US4266078A (en) *	1979-04-20	1981-05-05	Stauffer Chemical Company	N-Acylsulfonamide herbicidal antidotes
US4433997A (en) *	1979-04-20	1984-02-28	Stauffer Chemical Co	N-Acylsulfonamide herbicidal antidotes
US4495365A (en) *	1980-11-21	1985-01-22	Stauffer Chemical Co.	N-Acylsulfonamide herbicidal antidotes
US5110830A (en) *	1984-06-27	1992-05-05	Eli Lilly And Company	Benzenesulfonamides treatment of tumors susceptible to
US4845128A (en) *	1984-06-27	1989-07-04	Eli Lilly And Company	N([(4-trifluoromethylphenyl)amino]carbonyl)benzene sulfonamides
JP2679498B2 (ja) *	1991-12-25	1997-11-19	王子製紙株式会社	感熱記録体
CA2110524A1 (en) *	1992-12-10	1994-06-11	Gerald Burr Grindey	Antitumor compositions and methods of treatment
JPH0747772A (ja) *	1993-08-05	1995-02-21	New Oji Paper Co Ltd	感熱記録体
US5728712A (en)	1995-05-19	1998-03-17	Chiroscience Limited	3,4-disubstituted-phenylsulphonamides and their therapeutic use
DE69625622T2 (de) *	1995-10-25	2003-08-14	Senju Pharmaceutical Co., Ltd.	Angiogenese Inhibitoren
US5929097A (en) *	1996-10-16	1999-07-27	American Cyanamid Company	Preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
AU2879300A (en) *	1999-02-12	2000-08-29	Cellpath, Inc.	Methods for anti-tumor therapy
AR031130A1 (es)	2000-09-20	2003-09-10	Abbott Lab	N-acilsulfonamidas promotoras de la apoptosis
US20020055631A1 (en)	2000-09-20	2002-05-09	Augeri David J.	N-acylsulfonamide apoptosis promoters
US6720338B2 (en)	2000-09-20	2004-04-13	Abbott Laboratories	N-acylsulfonamide apoptosis promoters

2002
- 2002-05-24 CZ CZ20033296A patent/CZ20033296A3/cs unknown
- 2002-05-24 UA UA20031211105A patent/UA74889C2/uk unknown
- 2002-05-24 PT PT02729196T patent/PT1401806E/pt unknown
- 2002-05-24 US US10/478,389 patent/US7183320B2/en not_active Expired - Fee Related
- 2002-05-24 AU AU2002259204A patent/AU2002259204B2/en not_active Ceased
- 2002-05-24 MX MXPA03011197A patent/MXPA03011197A/es active IP Right Grant
- 2002-05-24 BR BR0210078-9A patent/BR0210078A/pt not_active IP Right Cessation
- 2002-05-24 IL IL15898502A patent/IL158985A0/xx unknown
- 2002-05-24 WO PCT/US2002/015142 patent/WO2002098848A1/en active IP Right Grant
- 2002-05-24 ES ES02729196T patent/ES2269688T3/es not_active Expired - Lifetime
- 2002-05-24 DE DE60213810T patent/DE60213810T2/de not_active Expired - Fee Related
- 2002-05-24 NZ NZ529098A patent/NZ529098A/en unknown
- 2002-05-24 CA CA002446719A patent/CA2446719A1/en not_active Abandoned
- 2002-05-24 SK SK1464-2003A patent/SK14642003A3/sk unknown
- 2002-05-24 EA EA200400006A patent/EA005810B1/ru not_active IP Right Cessation
- 2002-05-24 KR KR1020037015958A patent/KR100880760B1/ko not_active IP Right Cessation
- 2002-05-24 AT AT02729196T patent/ATE335722T1/de not_active IP Right Cessation
- 2002-05-24 JP JP2003501838A patent/JP4167173B2/ja not_active Expired - Fee Related
- 2002-05-24 PL PL02367188A patent/PL367188A1/xx not_active Application Discontinuation
- 2002-05-24 EP EP02729196A patent/EP1401806B1/en not_active Expired - Lifetime
- 2002-05-24 HU HU0400114A patent/HUP0400114A3/hu unknown
- 2002-05-24 DK DK02729196T patent/DK1401806T3/da active
- 2002-05-24 CN CNB028115104A patent/CN100475787C/zh not_active Expired - Fee Related
- 2002-06-03 TW TWPHENYLSULA patent/TWI266761B/zh not_active IP Right Cessation
- 2002-06-04 AR ARP020102075A patent/AR036079A1/es unknown
- 2002-06-04 EG EG2002060594A patent/EG24356A/xx active
- 2002-06-05 SV SV2002001076A patent/SV2003001076A/es not_active Application Discontinuation
- 2002-06-05 MY MYPI20022075A patent/MY136855A/en unknown
- 2002-06-07 PE PE2002000494A patent/PE20030199A1/es not_active Application Discontinuation
2003
- 2003-11-05 ZA ZA200308644A patent/ZA200308644B/en unknown
- 2003-12-02 EC EC2003004874A patent/ECSP034874A/es unknown
- 2003-12-02 NO NO20035366A patent/NO20035366L/no not_active Application Discontinuation
- 2003-12-03 HR HR20031000A patent/HRP20031000A2/xx not_active Application Discontinuation
- 2003-12-05 CR CR7182A patent/CR7182A/es unknown
2004
- 2004-09-14 HK HK04107015A patent/HK1064360A1/xx not_active IP Right Cessation
2006
- 2006-09-27 CY CY20061101396T patent/CY1105386T1/el unknown

Also Published As

Publication number	Publication date
ECSP034874A (es)	2004-01-28
US20040157741A1 (en)	2004-08-12
HRP20031000A2 (en)	2004-04-30
CA2446719A1 (en)	2002-12-12
KR100880760B1 (ko)	2009-02-02
NO20035366D0 (no)	2003-12-02
WO2002098848A1 (en)	2002-12-12
ES2269688T3 (es)	2007-04-01
JP2004530709A (ja)	2004-10-07
CR7182A (es)	2004-06-08
NO20035366L (no)	2004-02-06
AR036079A1 (es)	2004-08-11
EA200400006A1 (ru)	2004-06-24
ZA200308644B (en)	2005-02-07
EA005810B1 (ru)	2005-06-30
PE20030199A1 (es)	2003-03-12
EP1401806B1 (en)	2006-08-09
DE60213810D1 (de)	2006-09-21
HUP0400114A2 (hu)	2005-04-28
SK14642003A3 (sk)	2004-12-01
DK1401806T3 (da)	2006-11-27
BR0210078A (pt)	2004-06-22
SV2003001076A (es)	2003-07-29
UA74889C2 (en)	2006-02-15
CN1514824A (zh)	2004-07-21
NZ529098A (en)	2005-08-26
EP1401806A1 (en)	2004-03-31
TWI266761B (en)	2006-11-21
ATE335722T1 (de)	2006-09-15
DE60213810T2 (de)	2007-02-01
HUP0400114A3 (en)	2007-05-02
EG24356A (en)	2009-03-04
CZ20033296A3 (cs)	2004-04-14
MXPA03011197A (es)	2004-02-26
US7183320B2 (en)	2007-02-27
CN100475787C (zh)	2009-04-08
AU2002259204B2 (en)	2008-01-17
CY1105386T1 (el)	2010-04-28
PL367188A1 (en)	2005-02-21
KR20040007656A (ko)	2004-01-24
JP4167173B2 (ja)	2008-10-15
PT1401806E (pt)	2006-11-30
HK1064360A1 (en)	2005-01-28
MY136855A (en)	2008-11-28

Publication	Publication Date	Title
HK1064360A1 (en)	2005-01-28	Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents
EP1423120A4 (en)	2005-12-28	2H-PHTALAZINE-1-ONES AND METHODS OF USE THEREOF
PL367308A1 (en)	2005-02-21	Novel use
IL157845A0 (en)	2004-03-28	Anti-epileptogenic agents
GB0125088D0 (en)	2001-12-12	New use
GB0100762D0 (en)	2001-02-21	Novel use
GB0115181D0 (en)	2001-08-15	Novel use
IL160539A0 (en)	2004-07-25	Anti-influenzal agents
EP1367123A4 (en)	2005-10-12	NEUROTONIN AND ITS USE
GB0106031D0 (en)	2001-05-02	Use
GB2382026B (en)	2005-04-13	Multi-purpose support device
GB0106987D0 (en)	2001-05-09	Immunotherapeuitic agent
GB0122162D0 (en)	2001-10-31	Agent
GB2380440B (en)	2004-10-06	Sander
GB0119920D0 (en)	2001-10-10	New use
HUP0402141A3 (en)	2007-02-28	Herbicidal composition and process for its use
GB0003629D0 (en)	2000-04-05	Antitumour agent
GB0102482D0 (en)	2001-03-14	Use
GB0108115D0 (en)	2001-05-23	Use
GB0126186D0 (en)	2002-01-02	Use
GB0103892D0 (en)	2001-04-04	Use
GB0103899D0 (en)	2001-04-04	Use
CA92832S (en)	2001-06-29	Retractable monitor
GB0112544D0 (en)	2001-07-11	Novel use and compounds
GB0106487D0 (en)	2001-05-02	Agent